Laxmi Dental Limited
Laxmi Dental Limited (LAXMIDENTL) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Equipment & Supplies›Medical Equipment & Supplies
laxmidentallimited.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 62 Cr | 61 Cr | 66 Cr | 72 Cr | 66 Cr | 74 Cr | 75 Cr |
| Operating expenses (approx.) | 52 Cr | 51 Cr | 54 Cr | 61 Cr | 59 Cr | 60 Cr | 60 Cr |
| EBITDA | 10 Cr | 10 Cr | 12 Cr | 11 Cr | 7 Cr | 14 Cr | 14 Cr |
| OPM % | 15.6% | 15.7% | 18.2% | 15.3% | 10.5% | 18.3% | 19.2% |
| Other income | 0.59 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr |
| Interest | 2 Cr | 1 Cr | 0.46 Cr | 0.24 Cr | 0.32 Cr | 0.34 Cr | 0.30 Cr |
| Depreciation | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr | 4 Cr |
| Profit before tax | 6 Cr | 7 Cr | 11 Cr | 10 Cr | -0.20 Cr | 11 Cr | 13 Cr |
| Tax % | 18.2% | 36.7% | 21.5% | 17.9% | 1094.4% | 4.7% | 19.5% |
| Net profit | 5 Cr | 4 Cr | 8 Cr | 9 Cr | 2 Cr | 10 Cr | 10 Cr |
| EPS (₹) | ₹0.88 | ₹0.79 | ₹1.53 | ₹1.59 | ₹0.37 | ₹1.83 | ₹1.87 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|
| Sales | 239 Cr | 278 Cr | Sign in for TTM |
| Operating expenses (approx.) | 197 Cr | 234 Cr | Sign in for TTM |
| EBITDA | 42 Cr | 43 Cr | Sign in for TTM |
| OPM % | 17.5% | 15.6% | Sign in for TTM |
| Other income | 3 Cr | 9 Cr | Sign in for TTM |
| Interest | 5 Cr | 1 Cr | Sign in for TTM |
| Depreciation | 15 Cr | 16 Cr | Sign in for TTM |
| Profit before tax | 31 Cr | 31 Cr | Sign in for TTM |
| Tax % | 20.8% | 7.9% | Sign in for TTM |
| Net profit | 32 Cr | 29 Cr | Sign in for TTM |
| EPS (₹) | ₹6.06 | ₹5.53 | Sign in for TTM |
| Dividend payout % | 0.0% | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity capital | 11 Cr | 11 Cr |
| Reserves | 198 Cr | 232 Cr |
| Borrowings | 11 Cr | — |
| Other liabilities | 65 Cr | 50 Cr |
| Total liabilities | 285 Cr | 294 Cr |
| Fixed assets (net) | 41 Cr | 59 Cr |
| CWIP | 0.21 Cr | 0 Cr |
| Investments | 10 Cr | 27 Cr |
| Loans & advances | 0.17 Cr | 0.24 Cr |
| Inventories | 19 Cr | 22 Cr |
| Trade receivables | 37 Cr | 46 Cr |
| Cash & bank | 91 Cr | 8 Cr |
| Other assets | 87 Cr | 132 Cr |
| Total assets | 285 Cr | 294 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Cash from operating activity | 44 Cr | -5 Cr |
| Cash from investing | -29 Cr | -80 Cr |
| Cash from financing | 111 Cr | -18 Cr |
| Net cash flow | 125 Cr | -101 Cr |
| Free cash flow (OCF − Capex) | 28 Cr | -23 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| ROCE % | 16.5% | 13.4% |
| ROE % | 15.2% | 11.9% |
| Debtor days | 56 | 60 |
| Inventory days | 182 | 316 |
| Days payable | 313 | 155 |
| Cash conversion cycle | -75 | 220 |
| Debt / equity | 0.05 | 0.00 |
| Current ratio | 3.30 | 6.21 |
| Net debt / EBITDA | -1.90 | -0.19 |
Compare with peers
Loading peers…